[4-[[(2R,5S)-2-[3-(carbamoylamino)propyl]-5-[[2-[3-[3,5-di(prop-2-enoyl)-1,3,5-triazinan-1-yl]-3-oxopropyl]sulfanylacetyl]amino]-6-methyl-4-oxoheptanoyl]amino]phenyl]methyl (6S,6aS)-8-[(E)-3-amino-3-oxoprop-1-enyl]-4,6-dihydroxy-3-methyl-11-oxo-6a,7-dihydro-6H-pyrrolo[2,1-c][1,4]benzodiazepine-5-carboxylate
C50H62N10O13S — CID 158852932
Data last refreshed: (MolForge compound catalog, from PubChem)
About [4-[[(2R,5S)-2-[3-(carbamoylamino)propyl]-5-[[2-[3-[3,5-di(prop-2-enoyl)-1,3,5-triazinan-1-yl]-3-oxopropyl]sulfanylacetyl]amino]-6-methyl-4-oxoheptanoyl]amino]phenyl]methyl (6S,6aS)-8-[(E)-3-amino-3-oxoprop-1-enyl]-4,6-dihydroxy-3-methyl-11-oxo-6a,7-dihydro-6H-pyrrolo[2,1-c][1,4]benzodiazepine-5-carboxylate
[4-[[(2R,5S)-2-[3-(carbamoylamino)propyl]-5-[[2-[3-[3,5-di(prop-2-enoyl)-1,3,5-triazinan-1-yl]-3-oxopropyl]sulfanylacetyl]amino]-6-methyl-4-oxoheptanoyl]amino]phenyl]methyl (6S,6aS)-8-[(E)-3-amino-3-oxoprop-1-enyl]-4,6-dihydroxy-3-methyl-11-oxo-6a,7-dihydro-6H-pyrrolo[2,1-c][1,4]benzodiazepine-5-carboxylate (PubChem CID 158852932) has the molecular formula C50H62N10O13S and a molecular weight of 1043.17 g/mol. Its IUPAC name is [4-[[(2R,5S)-2-[3-(carbamoylamino)propyl]-5-[[2-[3-[3,5-di(prop-2-enoyl)-1,3,5-triazinan-1-yl]-3-oxopropyl]sulfanylacetyl]amino]-6-methyl-4-oxoheptanoyl]amino]phenyl]methyl (6S,6aS)-8-[(E)-3-amino-3-oxoprop-1-enyl]-4,6-dihydroxy-3-methyl-11-oxo-6a,7-dihydro-6H-pyrrolo[2,1-c][1,4]benzodiazepine-5-carboxylate.
Molecular Properties
| Compound Name | [4-[[(2R,5S)-2-[3-(carbamoylamino)propyl]-5-[[2-[3-[3,5-di(prop-2-enoyl)-1,3,5-triazinan-1-yl]-3-oxopropyl]sulfanylacetyl]amino]-6-methyl-4-oxoheptanoyl]amino]phenyl]methyl (6S,6aS)-8-[(E)-3-amino-3-oxoprop-1-enyl]-4,6-dihydroxy-3-methyl-11-oxo-6a,7-dihydro-6H-pyrrolo[2,1-c][1,4]benzodiazepine-5-carboxylate |
|---|---|
| PubChem CID | 158852932 |
| Molecular Formula | C50H62N10O13S |
| Molecular Weight | 1043.17 g/mol |
| Exact Mass | 1042.42 |
| IUPAC Name | [4-[[(2R,5S)-2-[3-(carbamoylamino)propyl]-5-[[2-[3-[3,5-di(prop-2-enoyl)-1,3,5-triazinan-1-yl]-3-oxopropyl]sulfanylacetyl]amino]-6-methyl-4-oxoheptanoyl]amino]phenyl]methyl (6S,6aS)-8-[(E)-3-amino-3-oxoprop-1-enyl]-4,6-dihydroxy-3-methyl-11-oxo-6a,7-dihydro-6H-pyrrolo[2,1-c][1,4]benzodiazepine-5-carboxylate |
| SMILES | C=CC(=O)N1CN(C(=O)C=C)CN(C(=O)CCSCC(=O)N[C@H](C(=O)C[C@@H](CCCNC(N)=O)C(=O)Nc2ccc(COC(=O)N3c4c(ccc(C)c4O)C(=O)N4C=C(/C=C/C(N)=O)C[C@H]4[C@@H]3O)cc2)C(C)C)C1 |
| InChI | InChI=1S/C50H62N10O13S/c1-6-40(64)56-26-57(41(65)7-2)28-58(27-56)42(66)18-20-74-25-39(63)55-43(29(3)4)37(61)22-33(9-8-19-53-49(52)71)46(68)54-34-14-11-31(12-15-34)24-73-50(72)60-44-35(16-10-30(5)45(44)67)47(69)59-23-32(13-17-38(51)62)21-36(59)48(60)70/h6-7,10-17,23,29,33,36,43,48,67,70H,1-2,8-9,18-22,24-28H2,3-5H3,(H2,51,62)(H,54,68)(H,55,63)(H3,52,53,71)/b17-13+/t33-,36+,43+,48+/m1/s1 |
| InChIKey | DMSDZIJMPOLIML-KRCMBNHXSA-N |
| XLogP | 2.29 |
| TPSA | 324.72 Ų |
| H-Bond Donors | 7 |
| H-Bond Acceptors | 14 |
| Rotatable Bonds | 22 |
| Heavy Atoms | 74 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1043.17 |
| LogP ≤ 5 | 2.29 |
| H-Bond Donors ≤ 5 | 7 |
| H-Bond Acceptors ≤ 10 | 14 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158852932 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.